These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 19638042)
21. The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate. Ongün S; Aslan G; Avkan-Oguz V Urol Int; 2012; 89(4):439-44. PubMed ID: 23006631 [TBL] [Abstract][Full Text] [Related]
22. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy. Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958 [TBL] [Abstract][Full Text] [Related]
23. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature. Miura T; Tanaka K; Shigemura K; Nakano Y; Takenaka A; Fujisawa M Int J Urol; 2008 May; 15(5):457-9. PubMed ID: 18452466 [TBL] [Abstract][Full Text] [Related]
25. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia]. Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058 [TBL] [Abstract][Full Text] [Related]
26. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. Adibi M; Hornberger B; Bhat D; Raj G; Roehrborn CG; Lotan Y J Urol; 2013 Feb; 189(2):535-40. PubMed ID: 22982426 [TBL] [Abstract][Full Text] [Related]
27. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. Schaeffer AJ; Montorsi F; Scattoni V; Perroncel R; Song J; Haverstock DC; Pertel PE BJU Int; 2007 Jul; 100(1):51-7. PubMed ID: 17552953 [TBL] [Abstract][Full Text] [Related]
28. Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Akduman B; Akduman D; Tokgöz H; Erol B; Türker T; Ayoğlu F; Mungan NA Urology; 2011 Aug; 78(2):250-5. PubMed ID: 21705048 [TBL] [Abstract][Full Text] [Related]
29. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266 [TBL] [Abstract][Full Text] [Related]
30. [Transrectal prostatic biopsy: the role of preventive measures]. Vaessen C; Janssen T; Schulman C Acta Urol Belg; 1997 Dec; 65(4):9-12. PubMed ID: 9497590 [TBL] [Abstract][Full Text] [Related]
31. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies. Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835 [TBL] [Abstract][Full Text] [Related]
33. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin. Lee JK; Lee S; Hong SK; Byun SS; Lee SE BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527 [TBL] [Abstract][Full Text] [Related]
34. [Transrectal biopsies of prostate and infection. Antibiotherapy or antibioprophylaxis?]. Lobel B Prog Urol; 1998 Sep; 8(4):578. PubMed ID: 9834526 [No Abstract] [Full Text] [Related]
35. Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative. Womble PR; Dixon MW; Linsell SM; Ye Z; Montie JE; Lane BR; Miller DC; Burks FN; J Urol; 2014 Jun; 191(6):1787-92. PubMed ID: 24345442 [TBL] [Abstract][Full Text] [Related]
36. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Mosharafa AA; Torky MH; El Said WM; Meshref A Urology; 2011 Sep; 78(3):511-4. PubMed ID: 21782225 [TBL] [Abstract][Full Text] [Related]
37. Prophylactic efficacy of cephamycin plus fluoroquinolones in high risk patients on inhibiting infectious complications after transrectal prostate biopsy. Shigemura K; Tanaka K; Yamamichi F; Arakawa S; Fujisawa M J Chemother; 2016 Dec; 28(6):513-516. PubMed ID: 26191982 [No Abstract] [Full Text] [Related]
38. Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk? Hori S; Sengupta A; Joannides A; Balogun-Ojuri B; Tilley R; McLoughlin J BJU Int; 2010 Nov; 106(9):1298-302; discussion 1302. PubMed ID: 20518764 [TBL] [Abstract][Full Text] [Related]